Please login to the form below

Not currently logged in
Email:
Password:

Q2 results 2012

This page shows the latest Q2 results 2012 news and features for those working in and with pharma, biotech and healthcare.

Lexapro generics hammer Forest Labs' Q3 results

Lexapro generics hammer Forest Labs' Q3 results. Sales down by nearly 40 per cent. ... Forest Laboratories saw sales in the third quarter of 2012 drop almost 40 per cent on the back of generic competition to its Lexapro antidepressant, which lost patent

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics